Thioglycosides as inhibitors of hSGLT1 and hSGLT2: Potential therapeutic agents 
for the control of hyperglycemia in diabetes

Castaneda, Francisco; Burse, Antje; Boland, Wilhelm; Kinne, Rolf K. H.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Thioglycosides as inhibitors of hSGLT1 and hSGLT2: Potential therapeutic agents for the control of hyperglycemia in diabetes

MPS-Authors

/persons/resource/persons98685

Castaneda, Francisco
Sonstige Wissenschaftliche Organisationseinheiten, Max Planck Institute of Molecular Physiology, Max Planck Society;

Burse, Antje
Max Planck Institute of Molecular Physiology, Max Planck Society;

Boland, Wilhelm
Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons98705

Kinne, Rolf K. H.
Sonstige Wissenschaftliche Organisationseinheiten, Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Castaneda, F., Burse, A., Boland, W., & Kinne, R. K. H. (2007). Thioglycosides as inhibitors of hSGLT1 and hSGLT2: Potential therapeutic agents for the control of hyperglycemia in diabetes. International Journal of Medical Sciences, 4(3): 1, pp. 131-139. Retrieved from http://www.medsci.org/v04p0131.htm.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0014-0749-6

Abstract

There is no abstract available